Corticotropin (ACTH) is the 39-amino-acid pituitary hormone that tells the adrenal glands to make cortisol. As a drug, it is a purified pig-pituitary product sold as Acthar Gel and Purified Cortrophin Gel. This guide covers its structure, mechanism, FDA-labeled uses, key evidence and label warnings. Sources were checked on November 17, 2026.
Quick answer: Corticotropin is a prescription hormone product made from pig pituitary glands. Acthar Gel is labeled for infantile spasms, multiple sclerosis flares and a range of rheumatic, skin, eye, lung and kidney conditions. Purified Cortrophin Gel has a similar list without infantile spasms. Neither label has a boxed warning.
Vitrapep does not sell corticotropin; this page is a reference summary of published research and regulatory information.
What is corticotropin?
Corticotropin, also called adrenocorticotropic hormone or ACTH, is a peptide hormone. ChEBI text in PubChem describes it as “a polypeptide hormone produced and secreted by the pituitary gland.” PubChem lists the formula C207H308N56O58S and a molecular weight of 4,541 g/mol (PubChem CID 16132265). With 39 amino acids, it falls under FDA’s 40-amino-acid cutoff for a protein, so it counts as a peptide (21 CFR 600.3). Our guide to peptide hormones gives background.
The drug products are natural extracts, not synthetic copies. The Acthar Gel label calls it “a naturally sourced complex mixture” of ACTH analogs and other pituitary peptides. Its major component is N-25 deamidated porcine ACTH (1-39), a modified pig form of the hormone. Manufacturing converts a porcine pituitary extract into this mixture, which is supplied in gelatin (Acthar label, 2026). The Purified Cortrophin Gel label describes “a porcine derived purified corticotropin (ACTH) in a sterile solution of gelatin” (Purified Cortrophin Gel label, 2026).
Drugs@FDA lists the original approval of Acthar Gel (NDA 008372) on April 29, 1952, now under Mallinckrodt Ireland (Drugs@FDA, Acthar Gel). Purified Cortrophin Gel (NDA 008975, ANI) was approved on June 16, 1954 (Drugs@FDA, Purified Cortrophin Gel).
Corticotropin: key facts
| Fact | Detail |
|---|---|
| Structure type | Linear 39-amino-acid peptide hormone; drug products are porcine-derived mixtures |
| Class | Adrenocorticotropic hormone (melanocortin peptide) |
| Molecular formula | C207H308N56O58S (PubChem) |
| Molecular weight | 4,541 g/mol (PubChem) |
| First FDA approval | April 29, 1952 (Acthar Gel, NDA 008372) |
| Brand names (US) | Acthar Gel; Purified Cortrophin Gel |
How does corticotropin work?
ACTH acts on the adrenal cortex, the outer layer of the adrenal glands. The Acthar label says Acthar Gel and natural ACTH stimulate it to release cortisol, corticosterone, aldosterone and weak androgens. The label also reports that Acthar Gel binds melanocortin receptors (Acthar label, 2026).
For infantile spasms, the label is direct: “The mechanism of action of Acthar Gel in the treatment of infantile spasms is unknown.” Pasireotide, covered in our pasireotide guide, works the other way: it lowers ACTH release in Cushing’s disease.
What is corticotropin approved for?
The Acthar Gel label lists these indications:
- infantile spasms, as monotherapy, in infants and children under 2 years of age;
- acute exacerbations of multiple sclerosis in adults;
- rheumatic disorders, as add-on short-term therapy: psoriatic arthritis, rheumatoid arthritis (including juvenile) and ankylosing spondylitis;
- collagen diseases: selected cases of systemic lupus erythematosus and systemic dermatomyositis (polymyositis);
- skin disease: severe erythema multiforme and Stevens-Johnson syndrome;
- serum sickness; severe allergic and inflammatory eye conditions such as keratitis, uveitis and optic neuritis; and symptomatic sarcoidosis; and
- nephrotic syndrome without uremia, idiopathic or due to lupus, to induce diuresis or remission of proteinuria.
The Purified Cortrophin Gel label covers similar categories, including multiple sclerosis flares, but does not include infantile spasms.
What did the key trials show?
The clinical study section of the Acthar label centers on infantile spasms.
Infantile spasms. A prospective, randomized, single-blinded human study enrolled 29 infants with infantile spasms. It compared ACTH with prednisone, a corticosteroid. Response required both an end to spasms and clearing of hypsarrhythmia, a chaotic EEG pattern, at 2 weeks. A blinded investigator judged the outcome. Thirteen of 15 infants (86.6%) responded to ACTH, versus 4 of 14 (28.6%) on prednisone (Baram et al., 1996).
The Acthar label presents this as its pivotal trial and reports p<0.002. In a crossover, 7 of 8 prednisone nonresponders (87.5%) then responded to Acthar Gel. FDA approved the infantile spasms use on October 15, 2010. The orphan drug database lists an orphan designation dated May 21, 2003, sponsored by Questcor Pharmaceuticals (FDA orphan drug database).
What side effects does the label list?
The Acthar label has no boxed warning. In infants with infantile spasms, its most common reactions (5% or more) are:
- increased risk of infections;
- convulsions;
- high blood pressure; and
- irritability and fever.
Postmarketing reports add asthenic conditions, fluid retention, insomnia, headache and increased blood glucose. The warnings largely mirror steroid effects. They cover infections, Cushing’s syndrome, and adrenal insufficiency after stopping. They also cover high blood pressure, salt and water retention, low potassium, and stomach or bowel perforation and bleeding. Others include mood changes, eye effects, reduced bone density and slowed growth in children.
Contraindications include scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex, recent surgery and peptic ulcer. Heart failure, uncontrolled high blood pressure and sensitivity to pig proteins are also on the list (Acthar label, 2026).
What is corticotropin’s regulatory status, and how is it used in research?
Corticotropin is a prescription drug in the United States. Both products are regulated under NDAs that date from the 1950s. DailyMed lists Acthar from Keenova ARD LLC and Purified Cortrophin Gel from ANI Pharmaceuticals. It also lists several homeopathic liquids naming corticotropin among many ingredients (DailyMed, 2026). The research summarized here is clinical: a human trial in infants.
Frequently asked questions about corticotropin
Is corticotropin a peptide?
Yes. Natural ACTH is a 39-amino-acid peptide hormone made by the pituitary gland.
Is Acthar Gel synthetic?
No. Its label calls it a naturally sourced mixture made from pig pituitary extract. Its main component is a modified porcine ACTH.
When was corticotropin approved?
Drugs@FDA lists the original approval of Acthar Gel on April 29, 1952.
How is corticotropin different from cosyntropin?
Corticotropin products contain the full 39-amino-acid hormone from pig pituitary. Cosyntropin is a shorter synthetic piece of ACTH. Our separate guide covers it.
Does corticotropin have a boxed warning?
No. Its warnings include infections, Cushing’s syndrome, high blood pressure and gut bleeding.
What to know now
- Structure: 39-amino-acid peptide hormone; drug products are porcine-derived mixtures.
- Approval: Acthar Gel, April 29, 1952; Purified Cortrophin Gel, June 16, 1954; prescription only.
- Mechanism: stimulates the adrenal cortex to release cortisol and other steroids.
- Evidence: 13 of 15 infants responded in the pivotal infantile spasms trial, versus 4 of 14 on prednisone.
- Safety: no boxed warning; warnings mirror steroid effects.
What we’re watching
Further Acthar label revisions on DailyMed, last revised in October 2026. Related guides: cosyntropin, pasireotide and pegvisomant.